AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MiNK Therapeutics, Inc. Director's Dealing 2021

Oct 21, 2021

34471_dirs_2021-10-20_cc417ae4-23a5-4821-b941-0288e9691365.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-13

Reporting Person: KLASKIN CHRISTINE M (Treasurer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	55660	Direct